Available Until 5/21/2025

Frontline Conversations: Enhancing Compliance with USP Chapter <797> in Small and Rural Hospitals


Content Release Date: June 17, 2024
Expiration Date: May 21, 2025
CE Credits: There is no CE credit with this activity
Activity Fee: Free

Activity Overview

Health systems have worked diligently to ensure that they are in compliance with the revised USP Chapter <797> requirements. This Frontline Conversations session will focus on small and rural facilities with expert faculty. This session follows two live webinars that summarized key revisions to the revised USP Chapter <797>, assessing facility and personnel, best practices for training and monitoring personnel, safety features of technologies and standardization of IV compounding, and how institutions can perform a gap analysis of its facility, personnel, polices, and environmental monitoring.   

No formal presentation was planned for this session. Attendees submitted questions for the faculty experts. 

More in this Series:

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems. 

At the conclusion of this activity, participants should be able to:

  • Perform a gap analysis that includes facility, personnel, policy and procedure development and review, environmental monitoring, and accreditation gaps.
  • Identify opportunities to implement technologies and standardization that improve safety of IV compounding in small, medium, and large institutions.

How It Works 

Questions pre-submitted during registration were addressed before live questions.

During the session, questions were submitted via the chat. 

Patricia C. Kienle, RPh, MPA, BCSCP, FASHP, Activity Chair 
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania 


More information on Patricia C. Kienle

Patricia Kienle, RPh, MPA, BCSCP, FASHP is Director of Accreditation and Medication Safety for Cardinal Health. She received her pharmacy degree from Philadelphia College of Pharmacy and Science and a Master in Public Administration degree from Marywood University in Scranton, Pennsylvania. She is author of The Chapter <795> Answer Book, The Chapter <797> Answer Book, and The Chapter <800> Answer Book and co-author of Meeting Accreditation Standards: A Pharmacy Preparation Guide. With over 600 invited presentations and 100 publications, she has special interests in medication safety, compounding sterile preparations, accreditation, and regulatory issues.

 

Orchid Motahari, PharmD, BCSCP, BCOP
Sterile Compounding Oversight
Martha's Vineyard Hospital
Oak Bluffs, Massachusetts 



More information on Orchid Matahari

Orchid Motahari, PharmD, BCSCP, BCOP, is the sterile compounding designated person and clinical oncology pharmacist at Martha’s Vineyard Hospital in Oak Bluffs, MA, where she oversees the sterile compounding operations, provides personnel training and ensures regulatory compliance. 

Michael Ganio, PharmD, MS, BCSCP, FASHP
Senior Director, Pharmacy Practice and Quality
ASHP
Bethesda, Maryland 

    

More information on Michael Ganio

Michael Ganio, PharmD, MS, BCSCP, FASHP joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug handling, and the ASHP Standardize 4 Safety initiative. Dr. Ganio earned his Pharm.D. from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Pharmacotherapy Specialist (BCPS) and a Board Certified Sterile Compounding Pharmacist (BCSCP). 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. The following persons in control of this activity’s content have relevant financial relationships:

  • Patricia C. Kienle: BD – Speaker’s Bureau

All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activit

Provided by ASHP

Supported by an educational grant from Pfizer Inc.